Wayfinding Financial LLC Takes Position in Aflac Incorporated (NYSE:AFL)

Wayfinding Financial LLC purchased a new stake in Aflac Incorporated (NYSE:AFL) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 2,168 shares of the financial services provider’s stock, valued at approximately $224,000.

Other large investors have also modified their holdings of the company. Whipplewood Advisors LLC acquired a new position in shares of Aflac in the 4th quarter valued at $26,000. Darwin Wealth Management LLC acquired a new position in shares of Aflac in the 3rd quarter valued at $34,000. BankPlus Trust Department acquired a new position in shares of Aflac in the 4th quarter valued at $34,000. Raelipskie Partnership acquired a new position in shares of Aflac in the 3rd quarter valued at $38,000. Finally, Curio Wealth LLC purchased a new stake in shares of Aflac in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Activity at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now directly owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 55,546 shares of company stock valued at $5,863,616 in the last three months. 0.80% of the stock is currently owned by company insiders.

Aflac Trading Down 0.6 %

AFL opened at $108.10 on Friday. The company has a market cap of $59.08 billion, a P/E ratio of 11.26, a PEG ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The business’s 50-day simple moving average is $105.95 and its 200-day simple moving average is $107.64.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, equities research analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Wells Fargo & Company cut their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 19th. Evercore ISI cut their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. JPMorgan Chase & Co. boosted their price objective on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Barclays cut their price objective on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, February 7th. Finally, Piper Sandler cut their price target on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Aflac currently has an average rating of “Hold” and a consensus target price of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.